Evidence map›Paper›PMID 41472709›Full record

ArticleFrontiers in cellular neuroscience2025

Development and characterization of a scalable calcium imaging assay using human iPSC-derived neurons.

Martin Dietrich Haustein, Caroline Deymier, Simon Schlienger, Laurane Lexcellent-Bissler, Jacques Mawet, Eric Gutknecht, Laure Thenoz, Pijus Brazauskas, Bérengère Renault, Stéphanie Brun and 2 more

Abstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Martin Dietrich HausteinCNS Translational Sciences, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Caroline Deymier *CNS Translational Sciences, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Simon Schlienger *CNS Translational Sciences, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Laurane Lexcellent-BisslerCNS Translational Sciences, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Jacques MawetCNS Translational Sciences, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Eric GutknechtCNS Translational Sciences, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Laure ThenozCNS Translational Sciences, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Pijus BrazauskasCNS Translational Sciences, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Bérengère RenaultCNS Translational Sciences, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Stéphanie BrunCNS Translational Sciences, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Simone WinistörferCNS Translational Sciences, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Thomas PortmannCNS Translational Sciences, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroscience drug discovery is challenged by the brain's structural and cell-type complexity, which is difficult to model in cellular systems compatible with high-throughput screening methods. Calcium oscillation assays, that harness neurons' intrinsic capability to develop functional neural networks in cell culture, are currently the closest cellular models with a relevant functional endpoint to model human neuronal circuitry in a dish. Here we further developed this useful assay towards scalable drug discovery applications. We show the importance of defined neuron-to-astrocyte ratios for optimal cellular distribution and surface adherence in HTS-compatible cell culture vessels and how the cell type ratios affect network firing patterns. Increasing the neuron density resulted in decreased network spike frequencies, but increased network spike amplitudes. We identified DAPT, a molecule previously shown to promote neuronal maturation and synapse formation, as a negative regulator of astrocyte viability. Furthermore, inclusion of GABAergic neurons in the cocultures increased the network spike frequency while reducing network spike amplitudes. The GABA

Indexed as

calcium imagingDAPTGABA inhibitionhuman iPSCneural network activityoscillation assayreprogramming

Identifiers

PMID41472709
PMCPMC12745381

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.